Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P21554 (
cannabinoid receptor
)
3,582
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Involvement of the type 1
cannabinoid receptor
(
CB1R
) in the effects of alcohol on the brain is supported by animal experiments, but how in vivo
CB1R
levels are altered in alcoholic patients is still unclear. To assess the short-time effects of a binge drinking episode on
CB1R
availability, 20 healthy social drinkers underwent [(18)F]MK-9470-positron emission tomography (PET) at baseline and after intravenous ethanol administration (ALC ACU). Moreover, 26 alcoholic patients underwent sequential
CB1R
PET after chronic
heavy drinking
(ALC CHR) and after 1 month of abstinence (ALC ABST). Seventeen healthy subjects served as controls. Compared with baseline, ALC ACU resulted in a global increase of
CB1R
availability (+15.8%). In contrast, a global decreased
CB1R
availability was found in ALC CHR patients (-16.1%) compared with controls, which remained unaltered after abstinence (-17.0%). Voxel-based analysis showed that ALC CHR patients had reduced
CB1R
availability, especially in the cerebellum and parieto-occipital cortex. After abstinence, reduced
CB1R
availability extended also to other areas such as the ventral striatum and mesotemporal lobe. In conclusion, whereas the acute alcohol effect is an increase in
CB1R
availability, chronic
heavy drinking
leads to reduced
CB1R
availability that is not reversible after 1 month of abstinence. Longer follow-up is required to differentiate whether this is a compensatory effect of repeated endocannabinoid overstimulation or an enduring trait-like feature. An enhanced
CB1R
signaling may offer a new therapeutic direction for treatment of the negative affective state produced by alcohol withdrawal and abstinence, which is critical for the maintenance of alcohol addiction.
...
PMID:Changes in cerebral CB1 receptor availability after acute and chronic alcohol abuse and monitored abstinence. 2455 24